SDS - Online Packet 10-5-2018

Section 11. Toxicological information

Inhalation

:

Adverse symptoms may include the following: respiratory tract irritation coughing nausea or vomiting headache drowsiness/fatigue

dizziness/vertigo unconsciousness reduced fetal weight increase in fetal deaths skeletal malformations

Skin contact

:

Adverse symptoms may include the following: irritation redness reduced fetal weight

increase in fetal deaths skeletal malformations :

Ingestion

Adverse symptoms may include the following: nausea or vomiting reduced fetal weight

increase in fetal deaths skeletal malformations

Delayed and immediate effects and also chronic effects from short and long term exposure

Potential immediate effects Short term exposure

: Not available.

Potential delayed effects : Not available.

Potential immediate effects Long term exposure

: Not available.

Potential delayed effects : Not available.

Potential chronic health effects

Not available.

General

:

Causes damage to organs through prolonged or repeated exposure. Once sensitized, a severe allergic reaction may occur when subsequently exposed to very low levels. Suspected of causing cancer. Risk of cancer depends on duration and level of exposure.

Carcinogenicity

:

No known significant effects or critical hazards. : Suspected of damaging the unborn child. : Developmental effects : No known significant effects or critical hazards. Fertility effects : Suspected of damaging fertility. Mutagenicity Teratogenicity

Numerical measures of toxicity

Acute toxicity estimates

Route

ATE value

Oral

206984.06 mg/kg 52949.41 mg/kg 358626.58 ppm

Dermal

Inhalation (gases)

Date of issue/Date of revision

: 12/19/2023

Date of previous issue

: 11/7/2023

Version : 5.02

19/24

AAA1754

Duraspar 440 Gray AAY1754

SHW-85-NA-GHS-US